Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.

Abstract

An approach toward the treatment of intracranial gliomas was developed in a rat experimental model. The authors investigated the ability of "professional" antigen-presenting cells (dendritic cells) to enhance host antitumor immune responses when injected as a vaccine into tumor-bearing animals.